Phenotypic and genotypic characterization of multidrug-resistant Acinetobacter baumannii isolated in Algerian hospitals.
Acinetobacter Infections
/ microbiology
Acinetobacter baumannii
/ classification
Algeria
Anti-Bacterial Agents
/ pharmacology
Bacterial Proteins
/ genetics
Drug Resistance, Multiple, Bacterial
Genotype
Hospitals
/ statistics & numerical data
Humans
Microbial Sensitivity Tests
Phenotype
beta-Lactamases
/ genetics
Algeria
Multidrug-resistant Acinetobacter baumannii
blaCTX-M-15
blaNDM-1
blaSHV-33
colistin-resistance
Journal
Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410
Informations de publication
Date de publication:
31 12 2020
31 12 2020
Historique:
received:
28
12
2019
accepted:
29
05
2020
entrez:
30
12
2020
pubmed:
31
12
2020
medline:
9
9
2021
Statut:
epublish
Résumé
The aim of this study was to investigate the drug-resistance and the molecular characterization of carbapenemases, ESBL, and aminoglycoside-modifying enzymes among Acinetobacter baumannii clinical isolates in Algerian hospitals. A total of 92 A. baumannii isolates were collected between 2012 and 2016. Antimicrobial susceptibility testings were performed for β-lactams, aminoglycosides, fluoroquinolones, trimethoprim-sulfamethoxazole, rifampicin and colistin. The phenotypic characterization of β-lactamases was investigated. For 30 randomly targeted strains, the carriage of the carbapenemases, ESBL and aminoglycoside-modifying enzymes -encoding genes was determined by PCR. Sequencing was carried out for carbapenemases and ESBL genes. Most of the 92 isolates studied were recovered from hospitalized patients (93.5%) and were mainly from intensive care units (51.1%) and orthopedics (19.6%). The strains were collected primarily from low respiratory tract (33.7%), wounds (23.9%) and urine (16.3%). Multidrug-resistant A. baumannii strains were prevalent (96.7%). High rates of resistance were observed for almost all antibiotics tested (>70%) excluding rifampicin (7.6%) and colistin (5.4%). For the five colistin-resistant strains, MICs ranged between 4 and 128 µg/mL. Positive MBL (83.7%) and ESBL (23.9%) strains were identified. Regarding β-lactams, the blaNDM and both blaSHV and blaCTX-M1 genes were detected in five and two strains respectively. Sequencing of the genes revealed the presence of blaNDM-1, blaCTX-M-15, and blaSHV-33. For aminoglycosides, aac(6')-Ib, ant(2'')-I and aph(3')-VI genes were detected in three, seven and six strains respectively. Here, we report the first co-occurrence of extended-spectrum β-lactamases SHV-33 and CTX-M-15, the carbapenemase NDM-1 and the emergence of colistin-resistant A. baumannii in Algerian hospitals.
Substances chimiques
Anti-Bacterial Agents
0
Bacterial Proteins
0
beta-Lactamases
EC 3.5.2.6
carbapenemase
EC 3.5.2.6
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1395-1401Informations de copyright
Copyright (c) 2020 Nabila Benamrouche, Ourida Lafer, Lahcen Benmahdi, Akila Benslimani, Wahiba Amhis, Houria Ammari, Farida Assaous, Amina Azzam, Kheira Rahal, Hassiba Tali Maamar.
Déclaration de conflit d'intérêts
No Conflict of Interest is declared